INCAP studies of hematologic and gastrointestinal function in healthy individuals and those with protein-energy malnutrition and infection.
Anemia is highly prevalent, especially in poorly nourished populations living in unsanitary conditions. Studies of the Central American population showed that iron was the predominant deficient hematopoietic micronutrient and that correction of nutrient deficiencies led to hematological normality as defined by WHO. The bioavailability of diverse iron compounds added to the mostly vegetable diets of such populations showed the superior absorption of chelated iron (NaFeEDTA) and its strong effectiveness in correcting iron deficiency when added to sugar. The consequences on development and mental behavioral functions as well as on work capacity of iron deficiency and anemia in infants, children and adults, and the positive effects of their correction was demonstrated. In protein-energy malnourished (PEM) children, the deficit in active tissue mass (basal oxygen consumption) and in total hemoglobin content were closely related. This relationship persisted as the rates of active tissue mass repletion was modified by levels of protein intake. This demonstrated the strong adaptive nature of hemoglobin content in response to oxygen needs in PEM and during recovery. Gastrointestinal functions in PEM and in populations demonstrated the bacterial invasion of the upper GI tract and how this resulted in secondary bile acids that are toxic to the intestinal mucosal cells impairing their absorptive functions. Environmental hygiene in populations reversed gut bacterial migration and improved GI function.
Viteri
Fernando E
FE
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, USA. fviteri@chori.org
D000047:Academies and Institutes / Q000266:history*; D018798:Anemia, Iron-Deficiency / Q000453:epidemiology / Q000266:history* / Q000503:physiopathology / Q000517:prevention & control; D002489:Central America / Q000453:epidemiology; D019422:Dietary Sucrose; D004492:Edetic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D005290:Ferric Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D005527:Food, Fortified / Q000266:history; D041981:Gastrointestinal Tract / Q000503:physiopathology*; D049673:History, 20th Century; D006801:Humans; D006920:Hygiene; D007239:Infections / Q000150:complications / Q000266:history* / Q000503:physiopathology; D018673:Nutrition Policy / Q000266:history; D009749:Nutrition Surveys; D011502:Protein-Energy Malnutrition / Q000150:complications / Q000178:diet therapy / Q000266:history* / Q000503:physiopathology
D019422:Dietary Sucrose; D005290:Ferric Compounds; D004492:Edetic Acid; C019179:Fe(III)-EDTA